HomeCompareFANDF vs PFE

FANDF vs PFE: Dividend Comparison 2026

FANDF yields 5.11% · PFE yields 6.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 FANDF wins by $283.6K in total portfolio value
10 years
FANDF
FANDF
● Live price
5.11%
Share price
$5.02
Annual div
$0.26
5Y div CAGR
43.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$333.2K
Annual income
$161,686.69
Full FANDF calculator →
PFE
Pfizer Inc.
● Live price
6.13%
Share price
$28.08
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$49.6K
Annual income
$26,258.71
Full PFE calculator →

Portfolio growth — FANDF vs PFE

📍 FANDF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodFANDFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, FANDF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
FANDF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

FANDF
Annual income on $10K today (after 15% tax)
$434.75/yr
After 10yr DRIP, annual income (after tax)
$137,433.69/yr
PFE
Annual income on $10K today (after 15% tax)
$520.66/yr
After 10yr DRIP, annual income (after tax)
$22,319.90/yr
At 15% tax rate, FANDF beats the other by $115,113.78/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of FANDF + PFE for your $10,000?

FANDF: 50%PFE: 50%
100% PFE50/50100% FANDF
Portfolio after 10yr
$191.4K
Annual income
$93,972.71/yr
Blended yield
49.10%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

FANDF
Analyst Ratings
2
Buy
Consensus: Buy
Altman Z
0.5
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-2.1% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

FANDF buys
0
PFE buys
8
PoliticianChamberTickerTypeAmountDate
Gilbert Cisneros🏢 House$PFE▲ Buy$1,001 - $15,0002026-02-10
Susan M. Collins🏛 Senate$PFE▲ Buy$15,001 - $50,0002026-02-03
James French Hill🏢 House$PFE▼ Sell$100,001 - $250,0002025-12-31
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-12-19
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-15
Ro Khanna🏢 House$PFE▼ Sell$1,001 - $15,0002025-09-05
Gilbert Cisneros🏢 House$PFE▼ Sell$1,001 - $15,0002025-08-05
Lisa McClain🏢 House$PFE▲ Buy$1,001 - $15,0002025-07-16
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
Ron Wyden🏛 Senate$PFE▼ Sell$1,001 - $15,0002025-06-03
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricFANDFPFE
Forward yield5.11%6.13%
Annual dividend / share$0.26$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR43.2%13.2%
Portfolio after 10y$333.2K$49.6K
Annual income after 10y$161,686.69$26,258.71
Total dividends collected$292.7K$58.3K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyHold

Year-by-year: FANDF vs PFE ($10,000, DRIP)

YearFANDF PortfolioFANDF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$11,432$732.42$9,153$693.39+$2.3KFANDF
2$13,353$1,120.62$8,593$849.25+$4.8KFANDF
3$16,040$1,751.73$8,336$1,066.78+$7.7KFANDF
4$19,979$2,816.02$8,437$1,384.80+$11.5KFANDF
5$26,071$4,694.19$9,013$1,875.40+$17.1KFANDF
6$36,094$8,198.18$10,306$2,680.72+$25.8KFANDF
7$53,811$15,189.90$12,820$4,101.38+$41.0KFANDF
8$87,885$30,307.12$17,673$6,826.70+$70.2KFANDF
9$160,281$66,244.10$27,543$12,591.86+$132.7KFANDF
10$333,187$161,686.69$49,560$26,258.71+$283.6KFANDF

FANDF vs PFE: Complete Analysis 2026

FANDFStock

FirstRand Limited, together with its subsidiaries, provides banking, transactional, lending, investment, and insurance products and services in South Africa, rest of Africa, the United Kingdom, and internationally. The company offers deposit and savings products; personal loans; and asset and invoice finance, as well as SME commercial, residential, and buy-to-let mortgages. It also provides life and short-term insurance products; card-acquiring services; and vehicle finance, installment credit and fleet management, and corporate and investment banking services. In addition, the company offers asset management, as well as vehicle-related insurance services. It serves retail, commercial, corporate, and public sector customers, as well as small business, agricultural, medium corporate, parastatal, and government entities. The company was incorporated in 1966 and is based in Sandton, South Africa.

Full FANDF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this FANDF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

FANDF vs SCHDFANDF vs JEPIFANDF vs OFANDF vs KOFANDF vs MAINFANDF vs JNJFANDF vs MRKFANDF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.